-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Fecal Microbiota Transplant As a Strategy to Mitigate Infection and Gvhd Following TCT

Program: Scientific Symposia
Session: Interrogating the Impact of the Intestinal Microbiome on Transplant and Cellular Therapies
Hematology Disease Topics & Pathways:
Research, Translational Research, Clinical Practice (Health Services and Quality), Clinical Research
Sunday, December 8, 2024, 9:30 AM-10:45 AM

Florent Malard, M.D., Ph.D.

Sorbonne Université, Hôpital Saint-Antoine, AP-HP, Service d'Hématologie Clinique et Thérapie Cellulaire,Centre de Recherche Saint-Antoine UMRs938, Paris, France

Disclosures: No relevant conflicts of interest to declare.

OffLabel Disclosure: My presentation will discuss us of MaaT013 and MaaT033 that are only use in clinical trial and compassionate use program and don't have any label at the moment.

See more of: Interrogating the Impact of the Intestinal Microbiome on Transplant and Cellular Therapies
See more of: Scientific Symposia
Previous Presentation | Next Presentation >>